Combination of Nilotinib and Pegylated Interferon Alfa-2B Results in High Rates of MR4.5 at 24 Months - Primary Analysis of the ALLG CML 11 Pinnacle StudyDavid T. Yeung,Naranie Shanmuganathan,Andrew Grigg,Ilona Cunningham,Jake Shortt,Philip Rowling,John Reynolds,Rosemary Anne Harrup,David M. Ross,David Kipp,Anthony K. Mills,Christopher K. Arthur,Anthony P. Schwarer,Kathryn Jackson,Nicholas Viiala,Robert Weinkove,Agnes S. M. Yong,Deborah L. White,Susan Branford,Timothy P. HughesBlood（2019）引用 4|浏览79AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
